Want to join the conversation?
Biopharmaceutical company $BXLT said the European Commission has authorized the marketing of its drug Obizur. Obizur is indicated for treatment of life-threatening acute bleeding disorder in adult patients with acquired haemophilia caused by antibodies to blood-clotting protein Factor VIII.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.